---
title: "KAISER JOHN JOSEPH — Ownership Dossier"
canonical: https://whiteintel.dev/entity/8cfee504-e95a-5480-8346-6d1ce0f7ca84
json: https://whiteintel.dev/api/public/dossier/8cfee504-e95a-5480-8346-6d1ce0f7ca84
identifier: sec:0001429406
jurisdiction: US
risk: Low
source: WhiteIntel corporate-ownership graph
---

# KAISER JOHN JOSEPH

**Type:** Company  
**Jurisdiction:** US  
**Identifier:** `sec:0001429406`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/8cfee504-e95a-5480-8346-6d1ce0f7ca84  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/8cfee504-e95a-5480-8346-6d1ce0f7ca84  

## Ownership & control

### Holdings / subsidiaries

- **Avalo Therapeutics, Inc.** (officer) — https://whiteintel.dev/entity/7ab53ad5-4202-5e5d-afb7-054c499320ac
- **ACADIA PHARMACEUTICALS INC** (officer) — https://whiteintel.dev/entity/e0daead6-1fdc-534a-ae81-4152b4e37d9f

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **KAISER JOHN JOSEPH**. Human view: https://whiteintel.dev/entity/8cfee504-e95a-5480-8346-6d1ce0f7ca84 · Structured JSON: https://whiteintel.dev/api/public/dossier/8cfee504-e95a-5480-8346-6d1ce0f7ca84._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._